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Transcripts of the bicistronic RNA3 of alfalfa mosaic virus were synthesized using the in vitro T7 run-off tran~~ption system. Synthetic RNA3 
containing one additional G nucieotide at the 5’ end were found to be infectious when coinoculated with RNA1 and RNA2 and coat protein. 
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1. INTRODUCTION 
Alfalfa mosaic virus (AlMV) is a plant virus with a 
genome composed of three capped messenger 
RNAs : RNA1 , RNA2 and RNA3. RNA1 and RNA2 
are monocistro~c [1,2] and code for proteins Pl and 
P2, respectively, proteins which are implicated in viral 
RNA replication. RNA3 is a bicistronic molecule [3-51 
expressing protein P3 encoded by the 5 ’ end cistron, 
whereas the 3 ’ end cistron, encoding the coat protein, 
is expressed through RNA4, a subgenomic RNA. P3 
protein is supposed to be involved in the movement of 
the virus through the plant [6]. Plant virus infection re- 
quires the three genomic RNAs plus RNA4 or the coat 
protein [7], 
Development of in vitro run-off transcription 
systems was used to synthesize infectious RNA 
transcripts of the plant viruses including beet necrotic 
yellow vein virus [8,9], brome mosaic virus [IO,1 11, 
cowpea chlorotic mottle virus [ 121, cowpea mosaic virus 
[13,14], tobacco mosaic virus [15,16], tomato rattle 
virus [ 171 and turnip crinkei virus 1181, in order to study 
the molecular biology of these viruses. Biolo~ic~ly ac- 
tive AlMV RNA4 transcripts have been described 
[19,20] and we gave evidence that a DNA piasmid carry- 
ing RNA3 cDNA of strain S was biologically active at 
a very low level [21]. Here we describe the construction 
of infectious RNA3 transcripts of strain S (RNA3-S). 
of the RNA3-S cDNA (cDNA3-S) opposite to the T7 promoter in the 
3pT71 plasmid containing the complete cDNA3-S [21]. For this pur- 
pose we cloned the 3 ’ end of RNA4, the subgenomic RNA of RNA3, 
with a synthetic oligodeoxynucleotide used as primer for the synthesis 
of a doubie-stranded (ds) DNA. The 3’ part of this primer hybridized 
to the last 19 nucleotides of the 3 ’ end of RNA4 and the 5 ’ part eon- 
tained the PstI restriction site. The first strand synthesis was for 30 
min at 37°C [22]. Then the RNAs were hydrolyzed by 0.3 M KOH for 
3 min at 90°C. The second strand was synthesized by reverse 
transcription in the same buffer used for the first strand synthesis for 
2 h at 2O”C, followed by a 30-min incubation at 37’C. The ds DNA 
produced was digested by PstI and ApaI enzymes to get a fragment 
of 241 base pairs. &?I was the closest unique restriction site to PstI 
in cDNA3-S. This fragment was introduced in a Ml3 vector contain- 
ing the EcoRI-PstI DNA fragment of the 3pT71 plasmid, correspon- 
ding to the complete cDNA3-S insert, cut by ApaI and Pstl enzymes. 
The PstI-ApaI fragment from a positive clone containing the 
modification was introduced in a 3pT71 plasmid digested by these two 
enzymes to give plasmid 3pT71(17,0). 
2.2. modification of the 5 ’ end of the transcripts 
2. MATERIAL AND METHODS 
2.1. Modification of the 3 ’ end of the transcripts 
A Pstl restriction site was introduced downstream of the extremity 
The junction between the T7 promoter and the cDNA3-S was 
modified by in vitro-directed mutagenesis [23] without enrichment for 
covalently close ds DNA. For this purpose the EcoRI-PstI DNA frag- 
ment from 3pT71(17,0), containing the 3 ’ modified complete 
cDNA3-S, was inserted in the vector PBS- (Stratagene) to get clone 
3BS-(12,0). All nucleotides between the first nucleotide transcribed 
from the T7 promoter and the first nucleotide of the cDNA3-S were 
removed using the single-stranded DNA form of this clone and an 
oligodeoxynucleotide as primer. The single-stranded form of plasmid 
3BS-(12,O) isolated as described by the manufacturer contained the 
DNA sequence corresponding to the RNA3 of plus polarity. The syn- 
thetic oligodeoxynucleotide used, GTGTAAGATGAAAACC- 
TATAGGAGTCGTA, contained 15 nucleotides at the 5 ’ end com- 
plementary to the 5’ end of RNA3-S and 15 nucleotides at the 3’ end 
complementary to the T7 promoter. Positive clones were identified 
with the labelled mutagenic primer. The presence of the modification 
was checked by’ sequencing for two clones: 3BS-(1,O)a and 
3BS-(1 ,O)b. 
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2.3. In vitro transcription 
BOX 9502, 2300 RA Leiden, The Netherlands 
Plasmids were digested by PstI enzyme. The protruding 3’ end 
generated by fitI was then removed with T4 DNA polymerase. The 
latter reaction was carried out for 30 min at 37°C in 50 mM Tris-HCl, 
pH 8.3, 15 mM (NH4)zS04,7 mM MgClz, 0.1 mM EDTA, 10 mM,& 
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mercaptoethanol, 0.2 pg/~l BSA, 50 PM each of dATP, dCTP, 
dGTP, dTTP containing 0.2 rg/$ of PstI-digested DNA and 0.1 
unit/p1 of T4 DNA polymerase (Strategene). The transcription of 5pg 
of plasmid digested by PstI and treated by T4 DNA polymerase was 
in 100~1 of 40 mM Tris-HCI, pH 7.5,6 mM MgC12,2 mM spermidine, 
10 mM dithiothreitol, 0.1 pg/pl BSA, 1 unit/p1 RNasin (Pharmacia), 
50pM GTP, 5OOhM each of ATP, CTP and UTP, 5OOpM m’GpppG, 
containing 50 units of bacteriophage T7 RNA polymerase 
(Strategene) for 1 h. After 30 min the GTP concentration was raised 
to 100 pM. After transcription nucleic acids were phenol-extracted, 
precipitated from ethanol, and aliquots corresponding to the 
transcription of 0.6 pg of DNA were used for the inoculations. 
2.4. Infectivity test and RNA3 detection 
The inoculation was done with 20~1 of a mixture containing 1.6,ug 
RNAl, 1.2 pg RNA2 prepared from the AlMV B strain as previously 
described [24] and coat protein from strain L prepared according to 
[25]. Young tobacco plants with three leaves (2-3 cm width) were 
used. RNAs were extracted from the inoculated leaf 6 days after in- 
oculation and from a systemic upper leaf 8 days after inoculation as 
indicated in [26]. RNA3 detection and strain characterization by 
primer extensions were done as in [24]. 
3. RESULTS 
T7 transcripts obtained with plasmid 3pT71, contain- 
ing the complete cDNA3-S and cut by a PstI enzyme 
were not infectious. These transcripts carry 17 non-viral 
nucleotides and the 5 ’ end and about 90 extra 
nucleotides including a non-viral polyA track at the 3 ’ 
end. However, both cistrons were functional in vitro 
(results not shown). In order to get infectious trans- 
cripts, both extremities of the cDNA3-S were modified 
to get T7 transcripts with only one additional G residue 
at the 5 ’ end and with a 3 ’ end identical to the natural 
RNA3. 
To synthesize transcripts without additional non- 
viral nucleotides at the 3 ’ end a PstI restriction site was 
created immediately downstream to the cDNA3-S at the 
extremity opposite to the T7 promoter in plasmid 
3pT71 (see section 2 and Fig. 1) to get plasmid 3pT71- 
(17,0). The numbers in parentheses indicate the number 
of additional non-viral nucleotides present in the T7 
transcripts at the 5 ’ and the 3 ’ end. A PstI site was in- 
troduced to linearize the plasmid by cutting the DNA 
strand used as template by the T7 polymerase just after 
the last nucleotide of the cDNA3-S (Fig. 1). 
The extremity of the cDNA3-S opposite to the PstI 
restriction site was fused to the first nucleotide 
transcribed from the T7 promoter to remove all addi- 
tional nucleotides, but one G, at the 5 ’ end of the 
transcripts. The final construction was made in vector 
BS containing the EcoRI-PstI DNA fragment from 
plasmid 3pT71(17,0) (section 2). 
Two clones 3BS-(1,O)a and b producing transcripts 
(1 ,O)a and (l,O)b, respectively, were selected. Prior to 
transcription, plasmids linearized with PstI were treated 
by T4 DNA polymerase to remove the 3 ’ protruding 
end. This treatment enhanced the amount of RNA3-S 
transcripts produced by the T7 polymerase and 
prevented the synthesis of RNA products of larger 
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Fig. 1. Schematic representation of the PstI site in clone 3BS-(1 ,O). 
The upper strand corresponds to the DNA sequence of plus-strand 
RNA3-S. The positions of the PstI cuts in the two strands are in- 
dicated by arrowheads. 
molecular weight ([27] and personal communication). 
Analysis of the transcription is shown in Fig. 2. The 
transcription of plasmids 3BS-( 1 ,O)a (lane 4) and b (lane 
6) producing transcripts (1 ,O)a and (1 ,O)b, respectively, 
was as efficient as transcription from plasmid 
3pUC9(2,0) (construction not shown) giving RNA3-S 
transcripts with two additional G nucleotides at the 5 ’ 
end (lane 2), but less efficient than with the 3pT71 
plasmid (result not shown). This is probably due to the 
nature of the sequence present downstream of the T7 
promoter [8,14,17]. 
Capped transcripts were used to complement a mix- 
ture of RNA1,2 of strain B and coat protein of strain 
425L. RNA 1 and 2 were purified from strain B of 
AIMV and coat protein from strain 425L because it is 
easy to distinguish RNA3 molecules of strain S, B and 
425L by primer extension [24] since the length of their 
leader is different ([4,5] and unpublished results). An 
oligodeoxynucleotide hybridizing specifically on all 
RNA3s in the P3 open reading frame near the AUG in- 
itiation codon was used as primer to synthesize full- 
length cDNA on RNA3 present in total RNA extracted 
from leaves. Then the length of the cDNA was analyzed 
in a sequencing el to identify the strain origin of the 
RNA3 reverse transcribed. The full-length cDNA is in 
increasing order RNA3-B, RNA3-S, RNA3-L [24]. 
In Fig. 3A, full-length cDNA synthesized on purified 
RNA of strain S is indicated with an S. Minor bands of 
strong stop products are also visible. When the mixture 
of RNAl, 2 and CP was not complemented (lane 1) or 
complemented with transcripts (2,0) (lane 2), no RNA3 
was detected in phenol extracts from inoculated leaf, 
Fig. 2. Analysis of the transcripts. Transcripts were analyzed on 
agarose gel stained with ethidium bromide. Analysis of plasmids 
3pUC9(2,0) (lanes 1 and 2), 3BS-(1,O)a (lanes 3 and 4) and 3BS-(1,O)b 
(lanes 5 and 6) is shown before (lanes 1, 3 and 5) and after (lanes 2, 
4 and 6) transcription. 
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Fig. 3. Detection of RNA3 in tobacco leaves infected with RNA3 
transcripts complemented with RNA1 and RNA2 of AIMV-B and 
coat protein of AIMV-L. (A) Analysis by primer extension of RNA 
extracted from virions of strain S is shown as a reference (lane R). The 
analyzed RNA were from inoculated leaves (lanes l-6) and from 
systemic non-inoculated leaves (lanes 7-10). The RNA were from 
plants inoculated with the mixture of RNA 1, 2 and CP (lane 1), the 
same mixture complemented with transcripts (2,0) (lane 2), with 
transcripts (1 ,O)a (lanes 3 and 7), with transcripts (1 ,O)b (lanes 4 and 
8), with equal amounts of transcripts (2,0), (1,O)a and (1,O)b (lanes 5 
and 9) and with RNA3-B (lanes 6 and 10). S and B indicate the posi- 
tion of the f~l-length cDNA obtained with RNA3 of strain S and 
strain B, respectively. (B) Same analysis as in (A) on RNA extracted 
from the inoculated leaf of plants inoculated with the mixture of 
RNAl, 2 and coat protein complemented with 3BS-(1,O)a plasmid 
after (lane 1) and before (lanes 2 and 3) transcription. As a control the 
analysis was done with RNA extracted from virus of strain S (lane 4). 
suggesting that RNA1 and RNA2 were not con- 
taminated by RNA3-B, that coat protein was not con- 
taminated by RNA3-L and that transcripts (2,0) were 
not able to complement this mixture. The mixture 
became infectious after complementation with 
RNA3-B. RNA3-B was detected in the inoculated (lane 
6) and the upper non-inoculated leaf (lane 10). The ad- 
dition of transcripts (l,O)a or (1,O)b to the mixture 
rendered the mixture infectious. In these cases the 
RNA3 detected in the inoculated and non-inoculated 
leaf was exclusively of strain S (lanes 3, 4, 7 and S), in- 
dicating that these transcripts were biologically active. 
The mixture complemented with equal amounts of 
transcripts (2,0), (1,O)a and (1,O)b was also infectious 
but RNA3 of strain S was only detected in the in- 
oculated leaf (lanes 5 and 9). This lower infectivity 
could be due to: (i) an inhibitory effect of DNA present 
in a three times higher amount in the inoculum than in 
the inoculum rubbed on the leaves analyzed in lanes 3 
and 4; (ii) the presence of transcripts (2,0); or (iii) both 
reasons. The second hypothesis is likely because all 
transcripts have the same 3 ’ end extremity. As 
transcripts (2,0) were not infectious in lane 2, they could 
compete with transcripts (1,0) for the first step of the 
RNA3 replication by the synthesis of non- or less func- 
tional minus-strand RNA3. These results indicate that 
only transcripts (1,O) were infectious. However, 
transcripts (2,0) could be infectious at a lower extent, 
not detected under the conditions of experimentation 
used here. As expected, transcripts (1,O) were also infec- 
tious when coat protein was replaced by RNA4 (result 
not shown). 
The mixture of RNAl, 2 and coat protein was com- 
plemented by BS-(I,O)DNA after (Fig.3B, lane 1) or 
before (lanes 2 and 3) transcription. As a reference, the 
primer extension was done with RNA extracted from 
virus of strain S (lane 4). The analysis of the inoculated 
leaf showed the presence of RNA3-S only in lane I, in- 
dicating that the infectivity was related to the presence 
of the transcripts (l,O). 
4. DISCUSSION 
According to these results, the infectivity of the 
transcripts corresponding to RNA3 of AlMV strain S 
was very sensitive to the number of non-viral nucleo- 
tides present at the 5’ end, as it was also noted for other 
plant viruses [8,11,14,15,17,18]. 
Only the RNA3-S transcripts with one additional G 
nucleotide were infectious. They will be used to study 
the molecular aspects of the virus multiplication. As 
previously reported, the amount of RNA3 relative to 
that of RNA4 extracted from the virions of strains S, B, 
and 425 L differed [24], and furthermore this ratio 
seems not to be influenced by the strain from which 
RNA1 and RNA2 originated (to be published). 
Since the major sequence differences between the 
RNA3 in the three AlMV strains are located in the 5 ’ 
non-coding region and because the intercistronic region 
is highly conserved, variations in the length or the struc- 
ture of the leader sequence will be created. The conse- 
quences of these modifications will be assessed by the 
study of the virus multiplication initiated by com- 
plementation of RNAl, RNA2 and RNA4 with 
transcripts from modified 3BS-(1 ,O) clones. 
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